Past events
Conference Call “Strategic Partnerships to Deliver CureVac’s COVID-19 Ambition”
February 5, 2021
CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), hosted a conference call and webcast on Friday February 5, 2021 at 4:00 p.m. CET / 10:00 a.m. EST.
Please find the corresponding press release, presentation slides, transcript and archived webcast below.
Downloads
Links